Financials
- Market Capitalization 518.16 M
- Employee 44
- Founded 2024
- CEO N/A
- Website www.crescentbiopharma.com
- Headquarter Cayman Islands
- FIGI N/A
- Industry İlaç Üreticileri - Genel
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-0.12
Fiyat/satışlar oranı
1.75
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 2130 | MAZE Maze Therapeutics, Inc. - Common Stock | 27.74 USD | +0.14% | +4.48% | +11.41% | -38.40% | 1.54 B USD | ||
| 2166 | RAPP Rapport Therapeutics, Inc. - Common Stock | 29.32 USD | -2.75% | -8.52% | -33.81% | +11.95% | 1.41 B USD | ||
| 3016 | EIKN Eikon Therapeutics, Inc. - Common Stock | 6.99 USD | -3.72% | -7.54% | -21.90% | -59.00% | 378.61 M USD | ||
| 3364 | QTTB Q32 Bio Inc. - Common Stock | 8.20 USD | -6.18% | +1.86% | -25.25% | +109.18% | 244.11 M USD |